Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiac Science, Inc.
Cardiac bedside monitor-defibrillator versus code blue protocol to be studied
April 26th, 2005
Cardiac Science Inc. (DFIB) announced that physicians at the University of Michigan Cardiovascular Center have launched a prospective study to assess the effectiveness of the bedside monitor-defibrillator, the Powerheart Cardiac Rhythm Module (CRM), against the traditional hospital "code blue" emergency response protocol. The CRM device is designed to continuously monitor at-risk cardiac patients and, when clinically appropriate, to deliver a defibrillation shock without intervention by a nurse or physician. The 2-phase study is being led by Kim A. Eagle, MD, Albion Walter Hewlett Professor of internal medicine, chief of clinical cardiology, and...
Source: Cardiovascular Business Week (2005-04-26)
|
